THC Biomed International Ltd THCBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.01–0.02
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.01 / $0.02
- Market Cap
- $2.54 Mil
- Volume/Avg
- 108,529 / 37,175
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
THC Biomed International Ltd operates as a licensed producer under Canada's Marijuana for Medical Purposes Regulations (MMPR). It is also engaged in the research and development of the products and services to medical marihuana. In addition, it is also engaged in providing horticulture training, record keeping and documenting research studies, and analytical services. Geographically all the activities are carried out through the region of Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 35
- Website
- https://www.thcbiomed.com
Valuation
|
Metric
|
THCBF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
THCBF
Financial Strength
|
Metric
|
THCBF
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.41 |
Interest Coverage | −4.85 |
Quick Ratio
THCBF
Profitability
|
Metric
|
THCBF
|
|---|---|
Return on Assets (Normalized) | −25.96% |
Return on Equity (Normalized) | −59.04% |
Return on Invested Capital (Normalized) | −28.59% |
Return on Assets
THCBF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hndwhxqpp | Zpj | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Yqcdbtzbym | Fdqwslz | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Msdkwlbfg | Pfkx | $41.4 Bil | |||
| Viatris Inc
VTRS
| Lrmqwqtl | Cwj | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Lmjxpxwcb | Dnt | $13.7 Bil | |||
| Catalent Inc
CTLT
| Mvbqhcnl | Hstsc | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Pdcmqkzbx | Srrt | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Smzqnnbh | Bnzskq | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hxjhwpmz | Gybng | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rsddypjk | Prz | $2.7 Bil |